Avalo Therapeutics CFO Christopher Ryan Sullivan disposes of 12,394 common shares for $202,436.79 - AVTX News | RalliesAvalo Therapeutics CFO Christopher Ryan Sullivan disposes of 12,394 common shares for $202,436.79
A
AVTX• CFO sells shares after option exercise
- Avalo Therapeutics CFO Christopher Ryan Sullivan sold 12,394 common shares at $16.33 on Sep. 16, 2026.
- The sale followed the exercise of stock options for 12,394 shares at $9.88.
- Directly held common shares fell to 39,900.
- Directly held stock options rose to 83,848.
